KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) Revenue (2018 - 2025)

BioNTech SE's Revenue history spans 8 years, with the latest figure at $43.2 million for Q4 2025.

  • On a quarterly basis, Revenue fell 100.0% to $43.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 99.95% decrease, with the full-year FY2025 number at $3.2 billion, up 2762.55% from a year prior.
  • Revenue hit $43.2 million in Q4 2025 for BioNTech SE, down from $1.8 billion in the prior quarter.
  • Over the last five years, Revenue for BNTX hit a ceiling of $3526.4 billion in Q4 2024 and a floor of $8.8 million in Q2 2025.
  • Historically, Revenue has averaged $178.7 billion across 5 years, with a median of $1.7 billion in 2023.
  • Biggest five-year swings in Revenue: soared 221500.66% in 2024 and later plummeted 100.0% in 2025.
  • Tracing BNTX's Revenue over 5 years: stood at $6.3 billion in 2021, then tumbled by 31.03% to $4.4 billion in 2022, then plummeted by 63.54% to $1.6 billion in 2023, then soared by 221500.66% to $3526.4 billion in 2024, then plummeted by 100.0% to $43.2 million in 2025.
  • Business Quant data shows Revenue for BNTX at $43.2 million in Q4 2025, $1.8 billion in Q3 2025, and $8.8 million in Q2 2025.